LINC00607 affects the proliferation and apoptosis of A549/DDP cells through inhibiting miR-372

Abstract

Abstract: Objective To explore the effect of LINC00607 on proliferation and apoptosis of lung cancer cisplatin-resistant cell line(A549/DDP) and its possible molecular mechanism. Methods The expressions of LINC00607 and miR-372 in lung cancer tissues, adjacent tissues, A549, A549/DDP cells were detected by real-time fluorescence quantitative PCR(RT-qOCR). A549/DDP cells were divided into pcDNA3.1 group, pcDNA3.1-LINC00607 group, (pcDNA3.1-LINC00607 + miR-NC)group, (pcDNA3.1-LINC00607 + miR-372)group. Methyl thiazolyl tetrazolium (MTT) assacy and colony formation experiments were used to test cell proliferation; flow cytometry was used to measure apoptosis; and Western blot was used to detect the expression levels of cleared-caspase-3 and Ki67; Dual luciferase reporter gene and RT-qPCR experiments confirmed the targeted regulation effect of LINC00607 on miR-372. Results Compared with adjacent tissues, the expression of LINC00607 in lung cancer tissues was significantly reduced, while the expression of miR-372 was significantly increased (P＜0.05). Compared with A549 cells, the expression of LINC00607 in A549/DDP cells was significantly reduced, while the expression of miR-372 was significantly increased (P＜0.05). Compared with pcDNA3.1 group, A549/DDP cell survival rate, clone formation numbers, Ki67 protein expression in pcDNA3.1-LINC00607 group were significantly decreased, and apoptosis rate and cleared-caspase-3 protein expression were significantly increased (P＜0.05). Compared with the (pcDNA3.1-LINC00607 + miR-NC)group, the A549/DDP cell survival rate, clone formation, Ki67 protein expression in the (pcDNA3.1-LINC00607 + miR-372)group were significantly increased, and the apoptosis rate, cleared-caspase-3 protein expression were significantly reduced (P＜0.05). LINC00607 targeted at and negatively regulated miR-372 expression. Conclusions LINC00607 inhibits proliferation and induces apoptosis of A549/DDP cells by down-regulating miR-372.

Key words: LINC00607, miR-372, A549/DDP cell line, drug resistance sensitivity

CLC Number:

R735

YANG Wen-chuan, HAN Dong, YANG Fan. LINC00607 affects the proliferation and apoptosis of A549/DDP cells through inhibiting miR-372[J]. Basic & Clinical Medicine, 2021, 41(7): 1001-1006.

References

[1]Nagasaka M, Gadgeel SM. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer[J]. Expert Rev Anticancer Ther, 2018, 18: 63-70.
[2]Sun QM, Hu B, Fu PY, et al. Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma[J]. Carcinogenesis, 2018, 39: 1438-1446.
[3]Zhao B, Xu H, Ai X, et al. Expression profiles of long noncoding RNAs in lung adenocarcinoma[J]. Onco Targets Ther, 2018, 11: 5383-5390.
[4]Wang C, Wang C, Qiu C, et al. Targeted regulation of FoxO3a by miR-372 to mediate gastric carcinoma cell apoptosis and DDP drug resistance[J]. Cancer Biother Radiopharm, 2020. doi: 10.1089/cbr.2019.3299.
[5]Wang Q, Liu S, Zhao X, et al. miR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma[J]. Cancer Med, 2017, 6: 1323-1330.
[6]Liu B, Pan CF, Ma T, et al. Long non-coding RNA AK001796 contributes to cisplatin resistance of non small cell lung cancer[J]. Mol Med Rep, 2017, 16: 4107-4112.
[7]Sun J, Pan LM, Chen LB, et al. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis[J]. Cell Cycle, 2017, 16: 2100-2107.
[8]曾玮, 陈平. 利用基因芯片重注释筛选肝细胞肝癌术后复发相关lncRNA[J].肿瘤学杂志, 2017, 23: 658-662.
[9]熊焕文, 夏国际, 吴冠楠. 晚期肺腺癌患者Ki-67表达水平与临床疗效的关系[J]. 医学研究生学报, 2018, 31: 55-58.
[10]杨忠信, 黄志昂, 潘丽红, 等. TPX2对人肺癌细胞增殖、凋亡及cleaved caspase-3表达的影响[J]. 解剖与临床, 2018, 23: 155-159.
[11]代会博, 马邦云, 张弘, 等. 升麻鳖甲汤加减方对人急性髓系白血病HL-60细胞增殖、凋亡及MAPK信号通路相关蛋白表达的影响[J]. 中医杂志, 2020, 61: 435-441.
[12]Tian LJ, Wu YP, Wang D, et al. Upregulation of long noncoding RNA (lncRNA) X-inactive specific transcript (XIST) is associated with cisplatin resistance in non-small cell lung cancer (NSCLC) by downregulating microRNA-144-3p[J]. Med Sci Monit, 2019, 25: 8095-8104.
[13]Sun H, Gao D. Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372[J]. BMC Cancer, 2018, 18: 1252-1262.
[14]Yeh LY, Yang CC1, Wu HL, et al. The miR-372-ZBTB7A oncogenic axis suppresses TRAIL-R2 associated drug sensitivity in oral carcinoma[J]. Front Oncol, 2020, 10: 47-57.